1Crowd — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Mynvax develops engineered protein subunit vaccines using a protein stabilization platform, including influenza vaccine candidates based on stabilized hemagglutinin regions and thermo-tolerant vaccines against SARS-CoV-2 variants.
BiotechDeep TechHealthtech
Co-investorsBIRACSID Venture PartnersLVX VenturesAccel
Optimus is a command center dashboard for ad operations teams that consolidates fragmented data sources into a unified platform for inventory, campaign delivery, and operational visibility.
AdTechSaaSBengaluru, IN
Kavita Shenoy(Founder)in
Co-investorsMela Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.